4046 Federal Register / Vol. 74, No. 13 / Thursday, January 22, 2009 / Notices 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Mechanism of 

Immunological Tolerance. 

Date: February 19, 2009. 

Time: 10 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6700B 

Rockledge Drive, Bethesda, MD 20817. 

Contact Person: Cheryl K. Lapham, PhD, 

Scientific Review Administrator, Scientific 

Review Program, DEA, NIAID/NIH/DHHS, 

6700–B Rockledge Drive, MSC 7616, Room 

3127, Bethesda, MD 20892–7616, 301–402– 

4598, clapham@niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: January 13, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–1156 Filed 1–21–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; The NIDDK-KUH 

Fellowship Review Committee. 

Date: February 2, 2009. 

Time: 10 a.m. to 2:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy 

Boulevard, Bethesda, MD 20892, (Telephone 

Conference Call). 

Contact Person: Xiaodu Guo, MD, PhD, 

Scientific Review Officer, Review Branch, 

DEA, NIDDK, National Institutes of Health, 

Room 761, 6707 Democracy Boulevard, 

Bethesda, MD 20892–5452, (301) 594–4719, 

guox@extra.niddk.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; Digestive Diseases 

and Nutrition Fellowships. 

Date: February 19, 2009. 

Time: 9 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Churchill Hotel, 1914 Connecticut 

Avenue, NW., Washington, DC 20009. 

Contact Person: Thomas A. Tatham, PhD, 

Scientific Review Officer, Review Branch, 

DEA, NIDDK, National Institutes of Health, 

Room 760, 6707 Democracy Boulevard, 

Bethesda, MD 20892–5452, (301) 594–3993, 

tathamt@mail.nih.gov. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; NIDDK Ancillary 

Studies in Kidney Diseases. 

Date: March 2, 2009. 

Time: 1 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy 

Boulevard, Bethesda, MD 20892, (Telephone 

Conference Call). 

Contact Person: Thomas A. Tatham, PhD, 

Scientific Review Officer, Review Branch, 

DEA, NIDDK, National Institutes of Health, 

Room 760, 6707 Democracy Boulevard, 

Bethesda, MD 20892–5452, (301) 594–3993, 

tathamt@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: January 13, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–1160 Filed 1–21–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

ODS Analytical Methods and 

Reference Materials Program—Dietary 

Supplement Element Methodology 

Workshop; Notice 

Notice is hereby given of the National 

Institutes of Health (NIH) Office of 

Dietary Supplements (ODS) Analytical 

Methods and Reference Materials 

Program, Dietary Supplement Element 

Methodology Workshop to be held 

Monday, March 23rd and Tuesday, 

March 24th, 2009 at the Marriott 

Gaithersburg Washingtonian Center 

Hotel in Gaithersburg, Maryland, 20878. 

Summary: Late in 2001, the U.S. 

Congress addressed the need for support 

of analytical methods and reference 

materials development related to dietary 

supplements. The Congressional 

appropriation language supported an 

increased ODS budget for several topics, 

including analytical methods and 

reference materials. The Senate 

language called for: ‘‘ODS to allocate 

sufficient funds to speed up an ongoing 

collaborative effort to develop and 

disseminate validated analytical 

methods and reference materials for the 

most commonly used botanicals and 

other dietary supplements.’’ 

On February 8, 2002, ODS held a 

public meeting to solicit comments to 

assist ODS in designing an overall 

strategy for implementing the 

Congressional mandate to foster 

development and validation of 

analytical methods and reference 

materials for dietary supplements. 

In Fiscal Years 2004 and 2005, 

Congress again used similar language 

supporting the Analytical Methods and 

Reference Materials Program in the ODS 

appropriations. 

On September 10, 2007, ODS held a 

Stakeholders’ Meeting to review the 

progress that had been made by the 

Analytical Methods and Reference 

Materials Program since its inception in 

2002 and to receive comments on future 

programmatic directions. 

As a follow-up to the 

recommendations from the 

Stakeholders’ Meeting, a Vitamin 

Methodology Workshop was held in 

July 2008. This workshop sought to 

evaluate the state of analytical 

methodology on vitamins suitable for 

dietary supplements and to identify 

gaps in the analytical science for the 

purpose of meeting future methods 

needs of stakeholders. Results of the 

Vitamin Methodology Workshop 

include an executive summary of the 


rmajette on PRODPC74 with NOTICES